Scholars Central

Review articlePublished 2015

Dexmedetomidine: The Anesthetic as an Antiarrythmic

Authors: Minati Choudhury

Cardiovascular Pharmacology: Open Access

Volume 4 · Issue 3 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cardiac arrhythmias are significant cause of morbidity and mortality during perioperative period as well as in critically ill patients in intensive care units (ICU).These rhythm disturbances that may be well tolerated in normal heart can cause significant hemodynamic instability in patients with a congenital or acquired heart problem. Management of these arrhythmias possess a challenge because currently available antiarrhythmic have several disadvantages. Dexmedetomidine (DEX) is a highly selective alpha-2 adrenergic receptor agonist with sympatholytic, sedative, amnesic and analgesic properties. Growing evidences has been suggested the potential therapeutic application of DEX in the management of cardiac rhythm disturbances. This work has an intention to review and update the application of DEX for management of various cardiac arrhythmias. A comprehensive review of pharmacology, mechanism of antiarrhythmic action and side effects of this drug is presented.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCardiovascular Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • SubjectCardiology
  • BylineArticles whose byline prints “Minati Choudhury”